the aid library

Filter

594

Estimating COVID-19 vaccine effectiveness against severe acute respiratory infections (SARI) hospitalisations associated with laboratory-confirmed SARS-CoV-2

World Health Organization WHO (2021) C_WHO

Many critical questions remain about the effectiveness of COVID-19 vaccines in real-world settings. These questions can only be answered in post-introduction vaccine effectiveness studies.This guidance document outlines an approach to leverage existing surveillance systems for Severe Acute Respirato ... more

Download

View PDF

Guideline for the pharmacological treatment of hypertension in adults
recommended

World Health Organization WHO (2021) C_WHO

The recommendations cover the level of blood pressure to start medication, what type of medicine or combination of medicines to use, the target blood pressure level, and how often to have follow-up checks on blood pressure. In addition, the guideline provides the basis for how physicians and other h ... more

Myocarditis and pericarditis after mRNA COVID-19 vaccination in children: Interim guidance

SickKids (2020) CC

Download

View PDF

African Antibiotic Treatment Guidelines for Common Bacterial Infections and Syndromes – Recommended Antibiotic Treatments in Neonatal and Pediatric Patients

Africa Centres for Disease Control and Prevention Center for Disease Dynamics, Economics & Policy (2021) CC

African Antibiotic Treatment Guidelines for Common Bacterial Infections and Syndromes – Final Report

Africa Centres for Disease Control and Prevention Center for Disease Dynamics, Economics & Policy Africa Centres for Disease Control and Prevention Center for Disease Dynamics, Economics & Policy (2021) CC

Download

View PDF

Comparison of national antimicrobial treatment guidelines, African Union

Craig, J.; K. Hiban, I. Frost, et al. World Health Organization WHO (2022) C_WHO

Bull World Health Organ 2022;100:50–59 | doi: http://dx.doi.org/10.2471/BLT.21.286689

Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

Van Katwyk, S. R.; Grimshaw, J. M.; et al (2019) C2

BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc ... e map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans. METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review. CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published. more

External Link

Chapter 17 Environmental, Health and Equity Effects of Urban Green Space Interventions

Hunter, R.F.; Cleary A. , Braubach M. (2019) CC

External Link

A Is tuberculosis elimination a feasible goal in Colombia by 2050?

López, L.; Y. Keynan, D. Marin et al. (2019) CC

Health Policy and Planning, Volume 35, Issue 1, February 2020, Pages 47–57, https://doi.org/10.1093/heapol/czz122 Colombia has an underreporting of 30% of the total cases, according to World Health Organization (WHO) estimations. In 2016, successful tuberculosis (TB) treatment rate was 70%, and t ... more

External Link

Climate Solutions Double as Health Interventions

Mailloux, N.A. et al. (2021) CC

Int. J. Environ. Res. Public Health 2021, 18(24), 13339; https://doi.org/10.3390/ijerph182413339 The climate crisis threatens to exacerbate numerous climate-sensitive health risks, including heatwave mortality, malnutrition from reduced crop yields, water- and vector-borne infectious diseases, and ... more

Guía de profilaxis Antibiótica Quirúrgica

La Sociedad Argentina de Infectología S.A.D.I. (2017) C2

Las infecciones del sitio quirúrgico (ISQ) constituyen una de las Infecciones Asociadas al Cuidado de la Salud (IACS) más frecuentes que ponen en riesgo a los pacientes llevando muchas veces al fracaso del procedimiento quirúrgico. Con una incidencia mucho mayor en países de medianos y bajos ing ... more

Informe Impacto de La Pandemia COVID-19 en las Enfermedades no Transmisibles en Chile 2022

Ministerio de Salud, Gobierno de Chile (2022) C1

Informe

Download

View PDF

Atención Farmacéutica y Seguimiento Farmacoterapéutico en APS

Ministerio de Salud, Gobierno de Chile (2018) C1

Basado en la Metodología POLARIS de Seguimiento Farmacoterapéutico, desarrollado por Facultad de Química de la Pontificia Universidad Católica de Chile.

External Link

Guía de Práctica Clínica Tratamiento Farmacológico de la Diabetes Mellitus tipo 2

Ministerio de Salud, Gobierno de Chile (2018) C1

2016-2017

Guideline for the pharmacological treatment of hypertension in adults recommended

Guideline for the pharmacological treatment of hypertension in adults
recommended